drug · small molecule
elraglusib
Phase 2updated 3mo agoby $ACTU ACTUATE THERAPEUTICS, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 2 investigational indications.
indications
indications
NSCLCBreast CancerProstate Cancer
targets
Glycogen synthase kinase-3 beta
all catalysts(0)
nothing on the calendar yet
Trials studying elraglusib
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that